$32.9 Million is the total value of Healthcare Value Capital, LLC's 11 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 46.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TYME | TYME TECHNOLOGIES INC | $13,239,000 | +20.8% | 2,075,000 | 0.0% | 40.26% | +83.6% | |
| GILD | GILEAD SCIENCES INC | $5,373,000 | -11.6% | 75,000 | 0.0% | 16.34% | +34.4% | |
| GILD | GILEAD SCIENCES INCcall | $4,298,000 | -11.6% | 60,000 | 0.0% | 13.07% | +34.4% | |
| NVLNF | Buy | NOVELION THERAPEUTICS INC | $3,120,000 | -49.7% | 1,000,000 | +13.5% | 9.49% | -23.5% |
| FLDM | Buy | FLUIDIGM CORP DEL | $2,418,000 | +33.1% | 410,500 | +13.9% | 7.35% | +102.2% |
| AMRN | AMARIN CORP PLCspons adr new | $1,805,000 | +14.6% | 450,000 | 0.0% | 5.49% | +74.1% | |
| GSK | GLAXOSMITHKLINE PLCsponsored adr | $1,774,000 | -12.6% | 50,000 | 0.0% | 5.40% | +32.8% | |
| BIS | PROSHARES TRultsh nasd biot | $551,000 | +7.2% | 25,000 | 0.0% | 1.68% | +62.9% | |
| APRI | New | APRICUS BIOSCIENCES INC | $184,000 | – | 100,000 | +100.0% | 0.56% | – |
| MNKD | New | MANNKIND CORPput | $116,000 | – | 50,000 | +100.0% | 0.35% | – |
| FCSC | FIBROCELL SCIENCE INCcall | $6,000 | -80.6% | 10,000 | 0.0% | 0.02% | -71.0% | |
| FLDM | Exit | FLUIDIGM CORP DELcall | $0 | – | -100,000 | -100.0% | -1.01% | – |
| DEPO | Exit | DEPOMED INCput | $0 | – | -420,000 | -100.0% | -4.87% | – |
| DEPO | Exit | DEPOMED INC | $0 | – | -700,000 | -100.0% | -8.11% | – |
| PFE | Exit | PFIZER INC | $0 | – | -250,000 | -100.0% | -17.86% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-01-23
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC | 20 | Q3 2021 | 31.3% |
| GLAXOSMITHKLINE PLC | 20 | Q3 2021 | 16.1% |
| PFIZER INC | 19 | Q3 2021 | 17.9% |
| TYME TECHNOLOGIES INC | 17 | Q3 2021 | 40.3% |
| ASTRAZENECA PLC | 14 | Q3 2021 | 12.9% |
| QUEST DIAGNOSTICS INC | 14 | Q3 2016 | 9.5% |
| CRYOLIFE INC | 13 | Q1 2017 | 6.6% |
| ANTARES PHARMA INC | 13 | Q3 2021 | 6.7% |
| AMARIN CORP PLC | 13 | Q3 2021 | 4.9% |
| CYTOKINETICS INC | 13 | Q3 2016 | 1.7% |
View Healthcare Value Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVELION THERAPEUTICS INC. | September 20, 2019 | 1,400,000 | 7.4% |
View Healthcare Value Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| SC 13D/A | 2019-09-20 |
View Healthcare Value Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.